Australia secures 20 M extra Astra Zeneca vaccine doses

On the basis of scientific advice, the Australian Government has secured an additional 20 million doses of the promising...

December 11, 2020 | Friday | News
Sinovac receives product license for 23-valent pneumonia vaccine

Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, has announced that the China National Me...

December 11, 2020 | Friday | News
Singapore to contribute $5,000,000 to COVID-19 Vaccine Global Access AMC mechanism

Singapore, like any other country, understands that the successful development of safe and efficacious vaccines is ...

December 9, 2020 | Wednesday | News
Malaysia joins CEPI donating $3 M to advance vaccine R&D

Malaysia has announced funding of $3 million to the Coalition for Epidemic Preparedness Innovations (CEPI) to help suppo...

December 9, 2020 | Wednesday | News
Sinovac secures $500M in funds for COVID-19 vaccine development

Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, has announced that Sinovac Life Sciences...

December 8, 2020 | Tuesday | News
INOVIO expands global manufacturing consortium for its COVID-19 vaccine candidate

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...

December 4, 2020 | Friday | News
EuBiologics partners with IVI for COVID-19 vaccine development

The International Vaccine Institute (IVI) and South Korean company EuBiologics exchanged an MOU to cooperate in the clin...

December 4, 2020 | Friday | News
Experts elaborate on Asia's confidence and challenges with COVID-19 vaccine

Vaccine confidence has never been more important, as the world waits for the first COVID-19 protection options to move t...

December 3, 2020 | Thursday | News
Pfizer and BioNTech achieve world first authorization for COVID-19 vaccine

Pfizer Inc. and BioNTech SE have announced that the Medicines & Healthcare Products Regulatory Agency (MHR...

December 2, 2020 | Wednesday | News
BioNTech-Pfizer apply CMA for COVID-19 Vaccine to the EMA

BioNTech SE and Pfizer Inc. on 30 Nov 2020 have submitted a formal Application for Conditional Marketing ...

December 2, 2020 | Wednesday | News
Korea contributes $3M to CEPI to advance vaccine development

The government of the Republic of Korea (ROK) has decided to contribute $3 million in 2020 for the first time to the Coa...

November 30, 2020 | Monday | News
AstraZeneca vaccine meet primary efficacy endpoint in preventing COVID-19

Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vacci...

November 27, 2020 | Friday | News
Korea inks MoU with Ecuador for global health R&D

The International Vaccine Institute (IVI) and Ministry of Foreign Affairs and Human Mobility of Ecuador exchanged a memo...

November 26, 2020 | Thursday | News
Sputnik V vaccine single dose to be less than $10 at international markets

The cost of one dose of the Sputnik V vaccine for international markets will be less than $10. Sputnik V is a ...

November 25, 2020 | Wednesday | News
Korea pushes vaccine R&D for global health

The International Vaccine Institute (IVI) and the Vaccine Innovative Technology ALliance Korea (VITAL-Korea) agreed to j...

November 24, 2020 | Tuesday | News
Hester Biosciences Nepal unveils live thermo-tolerant PPR vaccine

Hester Nepal recently got the regulatory approval and marketing authorisation from Department of Drug Administration (DD...

November 23, 2020 | Monday | News
CEPI's collaborative task force to assess COVID-19 vaccines on emerging viral strains

To rapidly monitor the emergence of new COVID-19 viral strains and evaluate their impact on vaccine candidates in develo...

November 23, 2020 | Monday | News
Pfizer, BioNTech demonstrate 95% efficacy of COVID-19 vaccine

Pfizer Inc. and BioNTech have announced that, after conducting the final efficacy analysis in their ongoing Ph...

November 23, 2020 | Monday | News